Stay updated on Blinatumomab & Pembrolizumab in B-ALL Clinical Trial

Sign up to get notified when there's something new on the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears on the error page, and the site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:24:58.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:39:40.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Access to the study page is blocked by a 403 Forbidden error, replacing the trial content with a minimal error screen and a Home link.
    Difference
    19%
    Check dated 2026-09-23T00:46:38.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page was updated to revision 3.7.0, replacing the previous 3.6.6. This reflects a software release without changes to the displayed study content.
    Difference
    0.1%
    Check dated 2026-09-15T23:37:50.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a minor site revision; this appears to update the page's underlying build rather than alter study details or content.
    Difference
    0.1%
    Check dated 2026-09-01T20:46:15.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page's Revision label was updated from v3.6.4 to v3.6.5. This is a minor site release/version update in the rendering/template and does not alter the study content or data displayed.
    Difference
    0.0%
    Check dated 2026-08-11T16:10:59.000Z thumbnail image

Stay in the know with updates to Blinatumomab & Pembrolizumab in B-ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page.